Nektar Therapeutics (NKTR) Amortizatization of Intangibles (2024 - 2026)

Nektar Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at -$1.7 million for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 25.6% year-over-year to -$1.7 million in Q1 2026; TTM through Mar 2026 was -$5.9 million, a 22.02% increase from a year earlier, with the FY2025 full-year figure at -$5.5 million, up 40.36% from the prior year.
• Amortizatization of Intangibles grew to -$1.7 million in Q1 2026 per NKTR's latest filing, from -$1.9 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at -$869000.0 in Q2 2025 and bottomed at -$3.1 million in Q1 2024.
• The 3-year median for Amortizatization of Intangibles is -$1.7 million (2026), against an average of -$1.8 million.
• Across the five-year window, Amortizatization of Intangibles surged 66.37% in 2025 and dropped 25.6% in 2026, its largest moves.
• Year by year, Amortizatization of Intangibles stood at -$1.5 million in 2024, then decreased by 23.08% to -$1.9 million in 2025, then increased by 11.92% to -$1.7 million in 2026.
• Per Business Quant, the three latest NKTR Amortizatization of Intangibles figures stand at -$1.7 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.4 million (Q3 2025).